VANCOUVER , Feb. 20, 2018 /CNW/ - MYM Nutraceuticals Inc., (CSE:MYM) (MYMMF) (MYM.CN) (MYM.CN) ("MYM") is pleased to announce it has closed its non-brokered private placement of 5,000,000 units at a price of $2.00 per unit for gross proceeds of $10,000,000 .
Due to the change in market conditions, the Company received approval from the CSE to reduce the price of this financing from $2.80 per unit to $2.00 per unit.
Each unit in the private placement is comprised of one common share and one transferable share purchase warrant with each warrant exercisable into one additional common share at a price of $3.00 for a period of two years. The securities will be subject to a four month and one day hold period under securities laws.
Insider buying of MYM shares
The following company insiders have purchased shares in the last Private Placement at $2.00 :
Sheryl Dhillon - 10,000 shares
Mark Forster - 35,200 shares
Total proceeds from insider share purchases was $70,400 . Total proceeds from Insiders, Founders, Family and Friends share purchases was over $9,000,000 . No commissions were paid for this private placement.
"All of us at MYM are very excited about the future of our company," said Rob Gietl , CEO of MYM. "This excitement extends to our family and friends who have participated in this non-brokered financing. We have many major milestones to achieve this year that will shape MYM for years to come. Continued global expansion and leveraging the relationships we have built, will ensure that MYM and its shareholders have a bright future."
Due to overwhelming interest, the company also announces that on February 12 th, 2018, a non-brokered private placement of up to 888,888 units at a price of CAD$2.25 per unit was registered with the CSE (Canadian Stock Exchange). Each unit will consist of one common share and one transferable share purchase warrant. Each whole warrant will entitle the holder to acquire one additional common share exercisable for a period of 24 months following the closing of the private placement at a price of CAD $3.25 per warrant share.
The private placement is subject to the approval of the Canadian Securities Exchange and the securities will be subject to a four-month and one day hold period under securities laws.
The Company intends to use the net proceeds from the private placement for general working capital and corporate purposes.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia . Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada , Germany and the USA under the following symbols: (CSE:MYM) (MYMMF) (0MY.F) (0MY.F) (0MY.MU) (0MY.SG).
ON BEHALF OF THE BOARD
Rob Gietl , CEO
MYM Nutraceuticals Inc.
Keep up to date with MYM on our social media channels:
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States . The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States ", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
SOURCE MYM Nutraceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/February2018/20/c1119.html